C.25
Standards call for all providers caring for adult patients to assess, recommend, vaccinate or
refer, and document vaccinations.
4
Leveraging each and every patient encounter to facilitate
education and provider recommendations for vaccines has been found to improve the likelihood
of a patient being immunized.
5
Immunization quality measures are a crucial tool for health care quality improvement and have
demonstrated effectiveness in improving immunization coverage across adult populations to
prevent illness and death, reduce caregiving demands, avoid unnecessary healthcare spending,
and set the foundation for healthy aging.
6
Quality measures, such as the AIS and PIS measures
can help to fill gaps and eliminate disparities in immunization.
Adult Immunization Status Measure
BIO recommends that the Workgroup replace the current adult influenza vaccine measure,
based upon Consumer Assessment of Healthcare Providers and Systems (CAHPS) surveys,
with the AIS measure. The AIS measure is a composite of several age-recommended vaccines
for adults, including the currently assessed influenza vaccine, and provides a sound, reliable,
and comprehensive means to assess the receipt of routine ACIP-recommended adult
vaccinations. It would enable states to monitor recommended adult immunization use beyond
influenza.
The Indian Health Service (IHS) Northwest Tribal Epidemiology Center and the National Nursing
Home Quality Care Collaborative first demonstrated that the AIS is an effective tool that can
improve patient health outcomes.
7
This measure, along with another composite measure for
prenatal immunization (see below), subsequently has been adopted as part of HEDIS through
efforts of the Department of Health and Human Services (HHS) Office of Infectious Disease and
HIV/AIDS Policy (OIDP) [formerly the National Vaccine Program Office (NVPO)] and the CDC in
collaboration with the National Adult Immunization and Influenza Summit Quality Working
Group. Additionally, the AIS was recently proposed for inclusion in the Medicare Shared
Savings Program, starting in performance year 2020, and the Medicare Merit-based Incentive
Payment System (MIPS), starting in performance year 2022. Within MIPS, inclusion was
proposed in several measure sets: allergy/immunology, family medicine, internal medicine,
obstetrics/gynecology, otolaryngology, preventive medicine, nephrology, general surgery,
oncology/hematology, infectious disease, rheumatology, geriatrics, skilled nursing facility, and
endocrinology. Alignment and harmonization of Medicare and Medicaid quality measures in this
way would further the federal government’s goals of consistency across quality programs.
We understand that the Workgroup did not recommend AIS for inclusion in the 2020 Medicaid
Adult Core Set of measures due to concerns about states’ ability to accurately and reliably
report this measure. The National Committee for Quality Assurance (NCQA) tested both
measures in Medicaid and commercial health plans. NCQA concluded that the fact that the
measures are drawn from Electronic Clinical Data Systems (ECDS), which include immunization
information systems (IIS), case management registries, claims, and electronic health records
(EHRs), makes them feasible to implement.